Vivos Therapeutics (NASDAQ:VVOS) announced that it will be hosting a women-led airway health-focused event at the Vivos Institute in Denver, Colorado, on February 1 and 2, 2024.
The company said the event, “Empowering Women to Champion Airway,” will bring together prominent women in the medical and dental fields to drive collaboration around airway health.
It comes after the company’s Complete Airway Repositioning and/or Expansion (CARE) oral device was approved for use to treat severe obstructive sleep apnea (OSA) by the United States Food and Drug Administration (FDA) on November 28, 2023.
“We are honored to host such an all-star lineup of world-renowned speakers with expertise in a variety of healthcare specialties—including medical sleep specialists, cardiologists, primary care physicians, pediatric specialists, orthodontists, and general dentists—all of whom work in one way or another with sleep and breathing disorders,” Vivos executive vice president Susie McCullough said in a statement.
“Fostering this type of interdisciplinary collaboration is necessary to increase the awareness that there is a new alternative to CPAP or surgery for treating severe OSA.”
U.S. and Canada licensed board-certified sleep specialist Dr. Manisha Witmans said she was grateful to be speaking at the event which she believes presents a tremendous opportunity to enhance collaboration between medical and dental professionals regarding the treatment of OSA patients.
“The recent FDA 510(k) clearance for Vivos’ CARE devices to address severe OSA is encouraging for both patients and clinicians as this gives medical professionals a new and potentially more desirable option to offer to their patients,” Dr. Witmans said.
“Collaborative efforts between medical doctors and dentists are essential to provide optimal treatment solutions for all patients."
Medical professionals interested in taking part in the conference can register for the event here.
Vivos Therapeutics (NASDAQ:VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on X, formerly Twitter, @emilyjjarvie